Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Pratik S Multani

4PUBLICATIONS

69CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Nov 06, 2025

Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations.

Melissa R Junttila, Claire E Repellin, Sumeet Salaniwal

|Aug 23, 2024

ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.

Christopher T Chen, Vishesh Khanna, Shivaani Kummar

|Jan 16, 2024

Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide.

Wassim Abida, Andrew W Hahn, Neal Shore

|Nov 30, 2018

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105.

Alexander Drilon, Siqing Fu, Manish R Patel

Pageof 1

Frequent Collaborators

3 joint publications

Melissa R Junttila

3 joint publications

Edna Chow Maneval

3 joint publications

Anneleen Daemen

2 joint publications

Jian Wang

2 joint publications

Alexander I Spira

2 joint publications

Shravani R Barkund

2 joint publications

Rongda Xu

2 joint publications

Aleksandr Pankov

2 joint publications

Maureen Duff

2 joint publications

Rupal Patel

Frequent Collaborators

3 joint publications

Melissa R Junttila

3 joint publications

Edna Chow Maneval

3 joint publications

Anneleen Daemen

2 joint publications

Jian Wang

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on : May 19, 2022

See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on : May 19, 2022

See more related videos